SUMMIT Clinical Trial Now Enrolling Mitral Valve Patients!
Written By: Adam Pick, Patient Advocate, Author & Website Founder
Page last updated: November 29, 2022; This post is sponsored by Abbott.
Why is the SUMMIT Clinical Trial such a big deal for millions of mitral valve patients who have limited treatment options?
Watch this educational video to learn about the new SUMMIT Clinical Trial that will evaluate the Tendyne™ Mitral Valve System that replaces the patient’s defective mitral valve without an incision to the patient’s sternum. The Tendyne™ therapy is a minimally-invasive alternative to open-heart surgery that does not require the patient to be on the heart-lung machine.
Are You A Candidate for the SUMMIT Clinical Trial?
To learn more about the SUMMIT Clinical Trial and to see if you qualify for this research study:
- Learn About the SUMMIT Clinical Trial
- Find Hospitals Near You Participating in the SUMMIT Clinical Trial
Keep on tickin!